BrightSpring Health Services, Inc.

BTSG· Nasdaq, Nasdaq· Services-Home Health Care Services

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
3.1%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
–
We record prices for the companies we cover; BTSG is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
219.8M
Revenue
$12.9B
Free cash flow
$394.7M
Owner earnings
$324.6M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
11.8%
Operating
2.3%
Net
1.5%
Free cash flow
3.1%
Owner earnings
2.5%
Stock pay
0.5%

Returns

ROIC, FY2025
5.2%
ROIC, 5 yr avg
–
ROE, FY2025
10.2%
ROE, 5 yr avg
–

Growth (CAGR)

Revenue, 3 yr
18.7%
Revenue, 5 yr
–
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–

Financial health · FY2025

Cash and investments
$88.4M
Total debt
$2.5B
Net debt
$2.4B
Debt/Equity
1.3x
Debt/FCF
6.4x

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
–

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$12.9B

+18.7% a year over 3 years

FY2022: Revenue $7.7BFY2023: Revenue $7.7BFY2024: Revenue $10.1BFY2025: Revenue $12.9B
FY2022FY2025

Margins

Gross11.8%Operating2.3%Net1.5%

FY2025

FY2022: Gross 17.5%, Operating 2.4%, Net -0.7%FY2023: Gross 14.8%, Operating 0.8%, Net -2.0%FY2024: Gross 12.6%, Operating 1.1%, Net -0.2%FY2025: Gross 11.8%, Operating 2.3%, Net 1.5%
FY2022FY2025

Free cash flow and owner earnings

Free cash flow$394.7MOwner earnings$324.6M

FY2025

FY2022: Free cash flow -$74.8M, Owner earnings -$78.3MFY2023: Free cash flow $137.3M, Owner earnings $133.3MFY2024: Free cash flow -$57.1M, Owner earnings -$126.3MFY2025: Free cash flow $394.7M, Owner earnings $324.6M
FY2022FY2025

Diluted shares

219.8M

+86.5% over 3 years, net dilution

FY2022: Diluted shares 117.8MFY2023: Diluted shares 117.9MFY2024: Diluted shares 193.0MFY2025: Diluted shares 219.8M
FY2022FY2025

Return on invested capital

5.2%

FY2025

FY2022: ROIC –FY2023: ROIC –FY2024: ROIC –FY2025: ROIC 5.2%
FY2022FY2025

Net debt (below zero)

-$2.4B

$2.4B more debt than cash

FY2022: Net cash –FY2023: Net cash -$3.4BFY2024: Net cash -$2.5BFY2025: Net cash -$2.4B
FY2022FY2025

Every figure, year by year

Fiscal yearFY2022FY2023FY2024FY2025
The business
Revenue$7.7B$7.7B$10.1B$12.9B
Revenue growth–-0.4%31.0%28.2%
Gross margin17.5%14.8%12.6%11.8%
Operating margin2.4%0.8%1.1%2.3%
Net income-$53.9M-$154.6M-$18.1M$190.7M
Net margin-0.7%-2.0%-0.2%1.5%
Diluted EPS$-0.46$-1.31$-0.09$0.87
Return on invested capital?–––5.2%
Cash
Operating cash flow-$4.7M$210.8M$23.8M$490.2M
Capital expenditure$70.1M$73.5M$80.9M$95.5M
Free cash flow-$74.8M$137.3M-$57.1M$394.7M
Stock-based compensation$3.5M$3.9M$69.2M$70.1M
Owner earnings?-$78.3M$133.3M-$126.3M$324.6M
Free cash flow per share$-0.63$1.16$-0.30$1.80
Capital allocation
Dividends paid––––
Share repurchases–$650.0K$650.0K$43.2M
Diluted shares117.8M117.9M193.0M219.8M
Share count change?–0.0%63.7%13.9%
Balance sheet
Cash and equivalents–$13.1M$61.0M$88.4M
Short-term investments––––
Total debt–$3.4B$2.6B$2.5B
Net debt–$3.4B$2.5B$2.4B
Shareholders' equity$754.8M$584.7M$1.6B$1.9B

Latest filings

All on EDGAR
2026-10-3010-QQuarterly report
2026-10-308-KEarnings release
2026-07-3110-QQuarterly report
2026-07-318-KEarnings release
2026-05-0110-QQuarterly report
2026-05-018-KEarnings release
2026-04-10DEF 14AProxy statement
2026-02-2710-KAnnual report
2026-02-278-KEarnings release
2025-10-2810-QQuarterly report

More from our coverage

All coverage